Navigation Links
GeneNews Announces Second Quarter Results
Date:8/7/2008

TORONTO, Aug. 7 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial results for the second quarter and year to date ended June 30, 2008.

"The launch of our first commercial product, ColonSentry(TM), a blood test to assess a patient's current risk of having colorectal cancer, marks the completion of our Company's transition into a fully commercial enterprise. ColonSentry is the world's first blood test for colorectal cancer screening and we believe this unique product will facilitate earlier detection and treatment of the disease, resulting in improved outcomes for patients with colorectal cancer," said Dr. Heiner Dreismann, Lead Director and Interim CEO of GeneNews. "Over the coming quarters, our focus will be on driving adoption of ColonSentry in Canada, subsequent launches of the test in Asia, the United States and Europe, and further development of our pipeline of innovative molecular diagnostic tests for a range of disease indications."

Highlights in the second quarter:

- Subsequent to quarter-end in July, launched the world's first blood

test for colorectal cancer screening in the Greater Toronto Area.

- Presented positive results in a Late Breaking Abstract at the

American Association of Cancer Research (AACR) annual meeting from a

validation study of a panel of six colorectal cancer biomarkers,

confirming (p less than 0.05) that the panel was able to stratify a

population with average risk for colorectal cancer into three defined

risk groups (Increased, Average, and Decreased Probability).

- Elected two additional independent members to the Board of Directors,

Mr. Harry A. Glorikian and Ms. Fran Tuttle.

Financial results (CDN dollars) for the three-month and
'/>"/>

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. GeneNews announces 2007 year end results
7. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
8. GeneNews Announces First Quarter Results
9. Genenews adds two members to its Board of Directors
10. GeneNews announces management changes to support commercialization of ColonSentry(TM)
11. GeneNews launches worlds first blood test for colorectal cancer screening

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...E, Mass., Nov. 7, Research project...red top marks this evening, as Tim Kunisky of Livi...(Jack) Chen of Audubon, PA received the highest ho... Competition in Math, Science & Technology, th.... ,, ( http://www.newscom.com/cgi-bin/prnh/200...
(Date:11/6/2009)...Mass., Nov. 6 Myriant Technologies...per and manufacturer of renewable bio-chemicals, ...nology provider Uhde GmbH, one of the world,s lead...unced an alliance for the engineering, procurement...ccinic Acid plants based on renewable feedstocks. ...
(Date:11/6/2009)... Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotec... "Company") today announced updated results from a...ents with sarcomas metastatic to the lung in a pos...sue Oncology Society Meeting held in Miami Beach, ...entation, entitled "A Phase II Study of Intravenou...
(Date:11/5/2009)...BURG, Md., Nov. 5 GenVec...ial results for the third quarter ended September ...on ($0.04 per share) for the three months ended Se...llion ($0.08 per share) in the comparable quarter ...009, GenVec,s net loss was $14.1 million ($0.15 pe...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...ution Agreement, GURGAON, India and PRINCETON, N....a wholly owned subsidiary of Ranbaxy,Laboratories ... several,agreements with AstraZeneca. Two of these...s. The third agreement pertains to Omeprazole 40mg...odipine ER capsules. All,of the agreements are spe...
...us, Inc.,today announced the appointment of Fisher...its new automated PLAC Test for the Hitachi, Hitac... to U.S. hospital clinical,laboratories. The new a...ood & Drug Administration (FDA) enabling the test ...rs., The PLAC Test is the only blood test cleared...
...asdaq: BNVI ) will present findings on the mechan...07 and BN108 at the American Association of,Cancer...ntion Center in San,Diego, CA, April 12 - 16, 2008...e pathway for cancer cell,apoptosis (cell death) i...a,Shtivelman, Director of Cancer Research at Biono...
Other Biology Technology:Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 2Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 3diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 3Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research 2
(Date:11/3/2009)... MADISON, WI, NOVEMBER 4, 2009 -- The world,s g...y among grape variety, human input, and something ...e vineyard site, soil, and climate. , Experts ...nce in a symposium on Wednesday, Nov. 4 in Pittsbu...ll be presented in two parts at the 2009 Annual Me...
(Date:11/3/2009)... The white shark may be the ultimate loner of the...trek, but a team of researchers has discovered tha...tern of migration that over tens of thousands of y...Ocean have separated themselves into a population ...world. , "White sharks are a large, highly mobil...
(Date:11/3/2009)... , LAKE ALFRED, FLLaser labeling of fruit and v... low-energy carbon dioxide laser beam is used to l...iminating the need for common sticker-type labels....iety of fruits and vegetables and is being used in.... It has been been approved in Asia, South Africa,...
Breaking Biology News(10 mins):Great wines come from great soils 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Laser etching safe alternative for labeling grapefruit 2Genes Linked to Cholesterol in Cells Are Identified 50935 1Genes Linked to Cholesterol in Cells Are Identified 50935 2Combating heart disease and stroke 3A Planning for a healthier Europe 50930 1European Consumers Share a High Interest in Healthcare but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences 50927 1European Consumers Share a High Interest in Healthcare but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences 50927 2European Consumers Share a High Interest in Healthcare but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences 50927 3
...rrent issue of CELL TRANSPLANTATION (Vol. 17:4) fe...king new ways to treat Parkinsons disease (PD), a ...ity, tremor and slowed physical movements related ...al ganglia of the brain, by using primate models t...ed cells. , One research team looked at the abili...
...and Technology (NIST) has developed Standard Refer... in folk medicine and now increasingly used in her...new materials to develop and test analytical metho...aterials for quality assurance of their measuremen...nce to address the use of bitter orange for health...
...l of Forest Research presents the preliminary find... landscape-scale experiments on how forest managem...The Blacks Mountain Interdisciplinary Research tea...versity, Oregon State University, U.C. Riverside, ...ciety scientists collaborating in research on larg...
Other Biology News:Neural cell transplants may help those with Parkinson's disease 2Neural cell transplants may help those with Parkinson's disease 3Bitter orange SRMs: Tools for product analysis/quality 2Pioneering landscape-scale research releases first findings 2
Calf Serum, Iron-Supplemented from Sigma-Aldrich
...NA Polymerase is a thermostable DNA polymerase der...ty at temperatures above 70°C, it was the fir...e predominant enzyme for that purpose. The enzyme ...ease activity, but lacks 3'--5' proofreading exonu...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
...radient system uses three Adept CE 4100 high pres... in one microlitre increaments. The Adept CE 4200...System control and data processing is provided by ... unit, CE 4900., Column heater/chillers can be su...
Biology Products: